Govt asks Serum Institute, Bharat Biotech to lower cost of COVID-19 vaccines, say official sources

The central authorities on Monday requested the Serum Institute and Bharat Biotech to decrease costs of their COVID-19 vaccines amid criticism from varied states who objected to profiteering throughout such a serious disaster.
The situation of vaccine pricing was mentioned at a gathering chaired by Cabinet Secretary Rajiv Gauba.

Now the 2 firms are anticipated to give you revised pricing for his or her vaccines.

The Hyderabad-based Bharat Biotech has mounted the value of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for personal hospitals.
The Pune-based Serum Institute of India (SII), the world’s largest vaccine maker when it comes to quantity, has introduced a value of Rs 400 per dose for its COVID-19 vaccine, ‘Covishield’, for state governments and Rs 600 per dose for personal hospitals.
Both vaccines can be found to the central authorities at a price of Rs 150 per dose.
Many states have objected to completely different costs of the vaccines, with Delhi Chief Minister Arvind Kejriwal saying this isn’t time for profiteering.

India has introduced growth of its COVID-19 vaccination drive by permitting its giant 18-plus inhabitants to get inoculated from May 1.